Biomarin Pharmaceutical Inc (BMRN)

Payables turnover

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Cost of revenue (ttm)	US$ in thousands	580,235	579,574	519,158	519,318	529,610	521,422	509,669	502,176	483,669	476,129	463,378	467,314	470,515	476,903	562,159	533,064	524,272	494,033	402,189	381,658
Payables	US$ in thousands	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Payables turnover		—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

December 31, 2024 calculation

Payables turnover = Cost of revenue (ttm) ÷ Payables
= $580,235K ÷ $—K
= —

The payables turnover ratio for Biomarin Pharmaceutical Inc has been marked as not available (—) for all the reporting periods provided from March 31, 2020, to December 31, 2024. The payables turnover ratio helps in evaluating how efficiently a company is managing its payables by measuring the number of times a company pays off its average accounts payable balance during a specific period.

Due to the unavailability of data for the payables turnover ratio, it is not possible to assess Biomarin Pharmaceutical Inc's efficiency in managing its accounts payable during the given periods. It is essential to have access to this ratio to understand the company's ability to negotiate favorable credit terms, maintain good relationships with suppliers, and effectively utilize its cash flows.

In order to provide a more in-depth analysis of Biomarin Pharmaceutical Inc's financial performance related to payables management, it would be necessary to obtain the specific values for the payables turnover ratio for the relevant periods.